Oroxcell
Oroxcell is a leading company founded in 2004, specializing in efficacy, ADME, and toxicity studies for pharmaceutical, cosmetics, nutrition, and chemicals industries. It develops alternative methods to animal testing, providing validated in vitro assays and services to support R&D projects. The company emphasizes innovation, scientific rigor, and collaboration with industrial and academic partners to advance in vitro testing technologies and applications.
Industries
Nr. of Employees
small (1-50)
Oroxcell
102 Avenue Gaston Roussel, 93230 Romainville, FRANCE
Products
Ready‑to‑use Caco-2/TC7 plated cells on Transwell inserts
Pre‑plated Caco-2/TC7 intestinal epithelial cells delivered on Transwell inserts (24‑ and 96‑well formats) to support intestinal absorption, permeability and intestinal pharmacology testing.
Ready‑to‑use Caco-2/TC7 plated cells on Transwell inserts
Pre‑plated Caco-2/TC7 intestinal epithelial cells delivered on Transwell inserts (24‑ and 96‑well formats) to support intestinal absorption, permeability and intestinal pharmacology testing.
Services
ADME assay services including absorption, metabolism, distribution and protein binding studies for screening through GLP study formats.
Comprehensive toxicology testing including genotoxicity, irritation/corrosion, sensitisation, phototoxicity, subcutaneous toxicity, drug‑drug interaction and complex mixture testing.
Tailor‑made efficacy and pharmacology assays for endpoints such as inflammation, metabolism modulation, anti‑aging, anti‑adipogenesis, tissue healing and pigmentation.
Collaborative development of novel and validated assays, including test specification, scientific validation, project management and support for publication.
Skin absorption, skin metabolism, skin distribution and a suite of dermato‑toxicology assays including RHE‑based tests and OECD guideline methods for irritation, corrosion, sensitisation and phototoxicity.
ADME assay services including absorption, metabolism, distribution and protein binding studies for screening through GLP study formats.
Comprehensive toxicology testing including genotoxicity, irritation/corrosion, sensitisation, phototoxicity, subcutaneous toxicity, drug‑drug interaction and complex mixture testing.
Tailor‑made efficacy and pharmacology assays for endpoints such as inflammation, metabolism modulation, anti‑aging, anti‑adipogenesis, tissue healing and pigmentation.
Collaborative development of novel and validated assays, including test specification, scientific validation, project management and support for publication.
Skin absorption, skin metabolism, skin distribution and a suite of dermato‑toxicology assays including RHE‑based tests and OECD guideline methods for irritation, corrosion, sensitisation and phototoxicity.
Expertise Areas
- In vitro ADME
- In vitro toxicology
- Dermato‑cosmetic safety and efficacy testing
- Intestinal absorption and Caco-2 permeability modeling
Key Technologies
- Caco-2/TC7 cell monolayers on Transwell
- Franz diffusion cells
- Reconstructed human epidermis (RHE)
- 3D organotypic tissue models
News & Updates
Latest News
Updates and news about Oroxcell's activities and projects.
Latest News
Updates and news about Oroxcell's activities and projects.